Skip to content
Peregrine
  • Home
  • About Us
    • Company Overview
    • Our Mission
  • Our Funds
  • Portfolio
  • Team
  • ESG & Impact
  • News
  • Contact
  • Home
  • About Us
    • Company Overview
    • Our Mission
  • Our Funds
  • Portfolio
  • Team
  • ESG & Impact
  • News
  • Contact

Amit Alfasi

ClearMargin

ClearMargin

Read More
IonaraBio

IonaraBio

Read More
Lutris Pharma Peregreine

Lutris Pharma 

Read More
start up nation Most active investor 2024 Healthcare

Peregrine Ventures recognized as Israel’s most active healthtech investor

Read More
Endostream Kaneka

EndoStream Medical acquired by Kaneka corporation

Read More

Bio ReFine™ achieves First-in-Human success with Coriofix™ system

Read More

Momentis Surgical™ achieves two FDA clearances in two weeks

Read More
Nectin Therapeutics Secures Global License Agreement with Immunome, Inc.

Nectin Therapeutics secures global license agreement with Immunome, Inc.

Read More
Cordio Medical

Cordio Medical partners with Iron Nation

Read More
Restore Medical, FDA

Restore Medical receives FDA Breakthrough Device Designation for the ContraBand™ System

Read More
Page1 Page2 Page3 Page4 Page5
  • Home
  • About Us
    • Company Overview
    • Our Mission
  • Our Funds
  • Portfolio
  • Team
  • ESG & Impact
  • News
  • Contact
Linkedin-in
©All rights reserved to Peregrine 2025

site by: 

razgroup-logo